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project brief

Quality of care received for family planning
from Community Pharmacists and Patent and
Proprietary Medicine Vendors in Lagos and
Kaduna, Nigeria: The IntegratE project
with PCN and the FMoH, is implementing three main
activities: (1) a pilot 3-tiered accreditation system for
PPMVs based on their healthcare qualifications; (2) a
pilot hub-and-spoke supervisory model to ensure
standard drug stocking practices; and (3) building the
capacity of CPs and PPMVs to provide expanded FP
services and report service statistics to the HMIS. Under
the pilot accreditation system, PPMVs are provided with
a standardized FP training and offer certain FP services
based on their tier (Table 1). CPs function outside of the
pilot accreditation system but would receive the same
training and provide the same services as Tier 2 PPMVs.
The IntegratE Project is simultaneously raising
awareness about the FP services CPs and PPMVs
provide. This brief focuses on quality of care received by
women voluntarily seeking FP services from CPs and
PPMVs. Additional information on IntegratE Project can
be found on www.integrateeproject.org.ng.

BACKGROUND
In Nigeria, Community Pharmacists (CPs) and Patent
and Proprietary Medicine Vendors (PPMVs) are the first
point of care for many communities. Although CPs and
PPMVs are not formally recognized as FP service
providers, 22% of modern contraceptive users’ report
receiving their last method from a PPMV and 12% from
a private pharmacy [2]. PPMVs are especially popular for
family planning (FP) due to their widespread availability,
consistent drug stocks, extended hours, personable
interactions, and no separate fees for consultations [3,
4]. As the Federal Ministry of Health (FMoH) explores
expanding its task sharing policy to include CPs and
PPMVs, evidence is needed on an effective regulatory
system to support PPMVs and CPs to provide high
quality FP services.
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THE INTEGRATE PROJECT
The IntegratE Project is a 4-year initiative (2017-2021)
funded by the Bill & Melinda Gates Foundation and MSD
for Mothers1 that seeks to increase access to
contraceptive methods by involving the private sector
(CPs and PPMVs) in FP service delivery in Lagos and
Kaduna States. IntegratE is implemented by a
consortium of partners, Marie Stopes International,
Planned Parenthood Federation of Nigeria, Population
Council, PharmAccess, and led by the Society for Family
Health. The project seeks to establish a regulatory
system with the Pharmacists Council of Nigeria (PCN) to
ensure that CPs and PPMVs provide quality FP services,
comply with FP regulations and report service statistics
to the Health Information Management System (HMIS).
To achieve this, the IntegratE Project in collaboration

1

1 This programme is co-funded by, developed and is being
implemented in collaboration with MSD for Mothers, MSD’s $500
million initiative to help create a world where no woman dies giving
life. MSD for Mothers is an initiative of Merck & Co., Inc., Kenilworth,
NJ, U.S.A
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Table 1: Description of tier accreditation system
Provider
type

Description

Training received

Tier 1
PPMVs

PPMVs without
healthcare
qualifications
PPMVs with
healthcare
qualifications
PPMVs who are
also pharmacy
technicians
Outside of
accreditation
system

• FP counseling and referral
• Refill of oral contraceptives

Tier 2
PPMVs
Tier 3
PPMVs
CPs

•
•
•
•
•
•
•
•
•

FP counseling and referral
Injectable administration
Implant insertion and removal
FP counseling and referral
Injectable administration
Implant insertion and removal
FP counseling and referral
Injectable administration
Implant insertion and removal

THE MAJORITY OF WOMEN (98%) FELT
THAT THEY WERE ALLOWED TO ASK
QUESTIONS DURING THEIR FP
COUNSELING SESSIONS WITH CPS
AND PPMVS

QUALITY OF CARE RECEIVED BY
CLIENTS SEEKING FAMILY
PLANNING SERVICES FROM CPS
AND PPMVS
The IntegratE project is conducting a mixed-methods
study to assess the effect of a series of interventions on
CPs’ and PPMVs’ capacity to provide high quality FP
services. Between June and November of 2019, women
were interviewed after receiving FP services from
trained CPs and PPMVs. 598 women who received FP
services from CPs in Kaduna and Lagos states were
contacted within a week of receiving services by a data
collector by phone about the services that they received.
Additional women will be enrolled in the study in 2020.

RESULTS
Respondent characteristics
Just over half of women interviewed were between the
ages of 25 and 34 (54%) in Kaduna, and 35 or older
(53%) in Lagos. Nearly all women in both states were
married or in-union (95% in Kaduna and 93% in Lagos)
and had at least one child (96% in Kaduna and 97% in
Lagos). Most had completed secondary school or higher
(58% in Kaduna and 79% in Lagos).

WOMEN REPORTED RECEIVING A
RANGE OF INFORMATION ABOUT
METHOD SELECTION, FROM A HIGH OF
96% WHO WERE TOLD ABOUT OTHER
FP METHODS TO A LOW OF 58% IN
LAGOS WHO WERE TOLD ABOUT
WHICH METHODS PROTECT AGAINST
STIS/HIV.
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Quality of care received
The measures of quality of care assessed in this study
are broken down into four key domains [6]: 1) respectful
care, 2) method selection, 3) effective use of selected
method, and 4) continuity of contraceptive use and care.
Figure 1 presents the proportions of women who
reported high quality by domain (n=4972). Respectful
care includes interpersonal interactions between the
provider and woman and assesses aspects of privacy
and confidentiality. In both states, women reported high

101 women were inadvertently skipped from the quality of care
questions
2
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Table 2: Respondent characteristics
Kaduna
(n=298)

Lagos
(n=300)

Total
(n=598)

Age
16-24

22.2

5.0

13.6

25-34

54.0

42.3

48.2

35-53
23.8
52.7
38.3
Marital Status*
Single
4.4
5.3
4.9
Married/ In-union
94.6
93.3
94.0
Widowed/divorced
0.7
1.3
1.0
Number of living children*
None
4.0
3.3
3.7
One
10.4
9.7
10.0
Two
23.2
15.0
19.1
Three
20.8
35.0
27.9
Four or more
41.3
37.0
39.1
Highest level of education achieved*
No formal education
12.8
3.3
8.0
Primary
18.8
14.0
16.4
Secondary
49.0
41.7
45.3
2+ years post-secondary
18.5
37.7
28.1
*Percentages do not total to 100% due to missing observations

quality of care for 5 of the 6 items in the respectful care
domain. Nearly all women felt that they were treated well
by the provider (99% in Kaduna and 100% in Lagos) and
that their information would be kept confidential (99%
in Kaduna and 96% in Lagos). Fewer in each state felt
that audio privacy was ensured during the visit (88% in
Kaduna and 91% Lagos), and that visual privacy was
ensured (66% in Kaduna and 74% Lagos).
Method selection focuses on information sought by
providers to facilitate women’s choice of method. At
least 90% of women in both states reported discussion
of 4 of the 7 items related to method selection. For
example, most women reported that the provider told
them about other FP methods (96% in each state) and
asked about their preferred method (95% in Kaduna
and 96% in Lagos). Fewer women reported aspects of
quality for the other 3 items. For example, providers
were trained not to promote any one method. Interviews
showed that in Lagos, 87% of women reported that no
method was strongly promoted, and 70% reported this
in Kaduna. Sixty-eight percent of women in Kaduna and
58% in Lagos reported that the provider gave them
information about FP methods that protect against STIs.

Figure 1: Percentage of women reporting quality of care received from CPs and PPMVs by domain and State n=497
99
100
98
98
98
98
99
96

RESPECTFUL CARE

Treated well by provider
Questions answered to satisfaction
Allowed to ask questions
Felt information will be kept confidential
88
91

Felt audio privacy
66

Felt visual privacy

74
96
96
95
96
92
95
91
95
89

METHOD SELECTION

Told about other methods
Asked about preferred FP method
Asked about previous FP experience
Asked about desire for another child
Asked about preferred timing of next child

80
70

Received information without any method promoted

CONTINUITY OF
CONTRACEPTIVE EFFECTIVE USE OF
USE AND CARE METHOD SELECTED

Received information on methods that protect against STIs

58

88

68
96
94
95
92

Told how chosen method works
Told how to use chosen method
Told about warning signs associated with method

66

Told about possible side effects of chosen method

66

Told how to manage side effects/problems

61

78
78
72

Told about timing of next visit
Given appointment card for follow up visit

82

Told about other sources of FP supply

76
80

Told about the possibility of switching method
0

25

50
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Effective use of the selected method includes
information about how to safely and effectively use the
method. Most women reported that the provider told
them how their chosen method works (96% in Kaduna
and 94% in Lagos) and how to use it (95% in Kaduna
and 92% in Lagos). Fewer reported that the provider told
them about the possible side effects of the chosen
method (78% in Kaduna and 66% in Lagos) and how to
manage those side effects (72% in Kaduna and 61% in
Lagos).
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Kaduna n=249
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FOR THEIR CHOSEN METHOD, 78% OF
WOMEN IN KADUNA AND 67% IN LAGOS
WERE TOLD ABOUT POSSIBLE SIDE
EFFECTS AND 72% OF WOMEN IN
KADUNA AND 61% OF WOMEN IN LAGOS
WERE TOLD HOW TO MANAGE THEM.

100

Continuity of contraceptive use and care includes
information about follow-up appointments and the
ability to switch to other methods. Most women were
told about the timing of their next FP visit (95% in
Kaduna and 90% in Lagos). Many were told that they
could switch to another method if the method selected
wasn’t suitable (89% in Kaduna and 82% in Lagos) and
about other sources of FP supply (84% in Kaduna and
80% in Lagos).

MORE THAN THREE-QUARTERS OF
WOMEN REPORTED RECEIVING EACH
ITEM IN THE CONTINUITY OF
CONTRACEPTIVE USE AND CARE
DOMAIN.

Level of quality of care received by
women seeking family planning from CPs
and PPMVs

In addition, 97% of women said they would return to the
same CP or PPMV for FP in the future, and 98% said they
would recommend the same provider to a friend3.

CONCLUSION
Results to date suggest that just over three-quarters of
women seeking FP services from IntegratE-trained CPs
and PPMVs received medium to high quality of care.
These findings are promising for the ability of CPs and
PPMVs to provide high quality care to clients seeking FP
services in Nigeria. The IntegratE Project plans to use
these results to help inform future FP counseling
trainings and mentorship support to CPs and PPMVs to
ensure that women seeking services from CPs and
PPMCs continue to receive high quality services.
Through additional client exit interviews planned for
Year 3 of the project, changes in quality of care received
from trained CPs and PPMVs will be assessed.

A composite scale combining the 22-items into low,
medium and high quality of care received was
calculated based on methods used in previous studies
[7]. Forty percent of women were categorized as
receiving high quality of care, 36% as medium quality of
care, and 24% as low quality of care.
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